EP4 blockade by L001 repressed the activation of pro-metastatic Hippo–YAP pathway, and facilitated the anti-cancer efficacy of gemcitabine with good tolerance and safety in a preclinical model of metastatic pancreatic cancer. The gene discussed is PTGER4; the disease is cancer.